Latigo Bio
Operator of a biotechnology company intended to develop novel and non-opioid therapies for chronic pain. The company's platform offers translated insights to provide a differentiated approach to targe...
Valuation
$530M
Market implied
Share Price
N/A
Total Raised
$304M
Last Round
N/A